Vision

Regen Lab SA, where innovation meets medical excellence

Regen Lab : A Success Story

Together, let’s make medical innovation a reality for all. It is a vision, a passion, and a commitment to a future where cellular regeneration opens doors to even more promising medical treatments.

Manufacturing sites

Employees

%

Scientists employees

Tubes per year

The Future of Regen Lab: Reaching New Horizons

The story of Regen Lab is far from over. Building on our experience and successes, we continue to explore new ways to improve the health and well-being of patients worldwide. Our team of researchers and developers works tirelessly to innovate and push the boundaries of regenerative medicine.

Global Expansion and International Recognition

Our success knows no borders. Regen Lab has conquered international markets with a dynamic growth strategy and continuous adaptation to the specific needs of each region. Our strategic partnerships with leading medical institutions and our presence at major global conferences testify to our leadership in the field of regenerative medicine.

3 regional manufacturing footprints for direct access to regulator agencies & close to markets

NEW YORK | U.S.A

Since : Q4 2021

Employees : 50

ISO 13485 | MDSAP

 

LAUSANNE | Switzerland

Since : 2009

Employees : 75

ISO 13485 | MDSAP | EU-MDR 2017/745

 

PARIS | France

To Start in  : 2024

Employees : 40

Certification targeted in Q4 2023

 

Since 2003, Regen Lab SA has been committed to the development of a unique expertise for the design and manufa​cturing of high-quality medical devices.

Copyright © 2024 All rights reserved.

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

RegenPRP™

RegenPRP™ est un traitement médical qui utilise le plasma riche en plaquettes provenant du sang du patient pour améliorer et la régénération tissulaire.

RegenPRP™ - HA

Cellular Matrix® est un traitement innovant combinant le plasma riche en plaquettes (PRP) et l'acide hyaluronique pour améliorer la régénération tissulaire et la guérison.

RegenPRP™ - ATS

RegenPRP™ combiné avec ATS (Autologous Thrombin Serum) est une approche avancée pour la régénération tissulaire qui utilise le plasma riche en plaquettes (PRP) enrichi en thrombine autologue pour maximiser les effets de guérison.

RegenExtracell®

RegenExtracell est un traitement innovant axé sur la régénération tissulaire qui utilise une matrice extracellulaire enrichie en plasma riche en plaquettes (PRP).

Hyaluronic Acid

L'acide hyaluronique est une substance naturellement présente dans le corps humain, particulièrement dans la peau, les articulations et les yeux.

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.

Safety & Privacy policies

WEBSITE PRIVACY NOTICE

We recommend you to acquaint yourself with the full content of our Privacy Policy.